Clinical Trials Browser

INDUSTRY × lazertinib × Other solid neoplasm × Clear all

NCT05541822 2025-05-22

To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation

Phase 2 Recruiting

Other solid neoplasm

Advanced Solid Tumors